Covivio
GSEFF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -1.6% | -2% | -11.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $1 | $0 |
| % Margin | 82.4% | 81.3% | 87.2% | 70.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | $0 | $1 |
| Operating Expenses | -$0 | $0 | $0 | $1 |
| Operating Income | $1 | $0 | $0 | $0 |
| % Margin | 117.3% | 43.7% | 38.3% | 33.8% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | -$1 |
| Pre-Tax Income | $1 | $0 | $0 | -$1 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | $0 | $0 | -$0 | -$1 |
| % Margin | 60.5% | 13.3% | -1.4% | -110.7% |
| EPS | 3.08 | 0.69 | -0.081 | -7.28 |
| % Growth | 346.4% | 949.8% | 98.9% | – |
| EPS Diluted | 3.06 | 0.69 | -0.081 | -7.28 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 83.3% | 57.3% | 80.6% | 39.7% |